Rocket Lab Corp 8-K

What Happened
Rocket Lab Corporation announced on April 14, 2026 that it completed the previously announced acquisition of Mynaric AG under the Stock Purchase Agreement dated September 25, 2025. The company paid aggregate consideration valued at $155.3 million at closing, consisting of a nominal cash payment and 2,277,002 shares of Rocket Lab common stock. The closing was disclosed via a press release furnished as Exhibit 99.1 under Regulation FD.

Key Details

• Closing date: April 14, 2026; Purchase Agreement dated September 25, 2025.
• Aggregate consideration at closing: $155.3 million (nominal cash + 2,277,002 shares issued).
• 109,943 shares of Rocket Lab common stock were deposited in an indemnity escrow.
• The transaction was structured on a base purchase price of $75 million plus additional investments by the sellers that reduced attainable earnout consideration; subject to post-closing purchase price adjustments, the sellers are no longer eligible for further earnout payments.
• Parties: Buyer was Rocket Lab USA, Inc. (a Rocket Lab subsidiary); sellers were OC III LVS LIII LP and CO Finance II LVS I LLC. Item 3.02 notes the reporting of unregistered sales of equity securities in connection with the transaction.

Why It Matters
The acquisition is a completed strategic transaction that involved issuance of over 2.27 million Rocket Lab shares, which affects the company’s outstanding share count and could have near-term dilution and escrow-related restrictions. The filing also indicates final consideration may be adjusted post-closing and that earnout obligations have been eliminated based on the closing structure. Investors should watch for follow-up filings (e.g., purchase price adjustments, any registration of the issued shares, and financial disclosures) to understand the transaction’s full financial and operating impact.